WESTON, Fla., June 17, 2004 (PRIMEZONE) -- Wall Street News Alert's "stocks to watch" this morning are: Cell Bio-Systems, Inc. (Pink Sheets:CBSI), Genta Incorporated (Nasdaq:GNTA), One Voice Technologies (OTCBB:ONEV) and Odyssey Healthcare Inc. (Nasdaq:ODSY).
Aggressive investors and traders need to be watching Cell Bio-Systems, Inc. (Pink Sheets:CBSI) this morning! Yesterday after the markets closed, the company issued a press release announcing that John Johnson, president of Tulip Medical and a widely respected innovator of bio-device products for the plastic and cosmetic surgery Industry, has joined the Board of Directors!
This should be super news for investors! Cell Bio-Systems, a biotechnology company positioned to manufacture and distribute patented, disposable technologies for cosmetic surgery and other living tissue procedures, states that Johnson brings more than 30 years experience in the research and development of products that have represented major advancements in live tissue management. He holds numerous patents and has been a key force in the development of Cell Bio-Systems' product line.
The company will begin limited production of its flagship instrument, the Super-Luer injector next week. Utilizing the company's approved tip styles, these early products will allow Cell Bio-Systems to establish manufacturing protocols and complete a pending 510K notification to the FDA in support of the company's claims.
Investors need to keep their eyes on this company! The Super-Luer is a patented connection system that will serve as the centerpiece component for the company's bio-device kits utilized in procedures ranging from liposuction and fat re-injections to gene therapy technologies and stem cell research. It will be adapted to manufacture the first affordable, disposable cannula in the marketplace.
The stock closed yesterday at about fifty-two cents a share.
In case you are not familiar with the company: Based in San Diego, California, Cell Bio-Systems is the exclusive licensee of two patented syringe connection products that it plans to adapt as disposable devices for liposuction and other Living Tissue Management(TM) procedures. The company is developing an affordable, disposable product line that will fill this void in the cosmetic surgery and living tissue marketplace. The company's patented, groundbreaking technology will increase patient safety and enhance procedural outcomes. Most notably, Cell Bio-Systems devices can be adapted for a variety of procedures, ranging from fat transfers to biopsies to stem cell research. The company ultimately will develop a complete living tissue management system.
Stocks showing interesting activity yesterday were: Genta Incorporated (Nasdaq:GNTA) up 20% on 7.5 million shares traded, One Voice Technologies I (OTCBB:ONEV) up 15.2% on 7.1 million shares traded and Odyssey Healthcare Inc. (Nasdaq:ODSY) up 9.8% on 1.3 million shares traded.
Commentary:
"The Federal Reserve in a monthly report, the Beige Book, reported Wednesday that inflation increases were modest, that jobs were being added to the payrolls at a better than expected clip, and that lending and housing numbers were considered strong. Gasoline prices the last week fell from the $40.50 per barrel spike to just over $37 per barrel," stated Sonja Rudd in Wall Street News Alert's daily commentary continued at: http://www.WallStreetNewsAlert.com.
WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 18 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at http://www.wallstreetnewsalert.com and select the "join now" button.
-- Wall Street News Alert is not affiliated with faxes bearing the names Wall Street Stock Alert or Wall Street News Alert! --
Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies' discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.
This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. (WSCF has been compensated One Hundred and Ten Thousand shares of Cell Bio-Systems, Inc. (Pink Sheets:CBSI), by a third party (Jon Farber), who is non-affiliated and may hold a significant position in the stock, for services provided including dissemination of company information in this release. WSCF has not sold any of those shares, as of this release. WSCF may intend to immediately begin or continue selling its shares as this release is being circulated. WSCF may receive additional shares for extension of its services. Any additional shares will be disclosed at such time that WSCF is aware of a clients desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock. Market commentary provided by Sonja Rudd.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.